SCHEMBL8937682

SCHEMBL8937682

CCc1c[nH]c(=O)c2cc(F)c(OC3CCN(Cc4ccc(Cl)cc4)CC3)cc12

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
HRH1 P35367 3/20 0.42
CCR3 P51677 3/20 0.42
OPRM1 P35372 3/20 0.40
POLB P06746 1/20 0.39
CCR5 P51681 1/20 0.38
BCHE P06276 1/20 0.38
ACHE P22303 1/20 0.38
KCNH2 Q12809 1/20 0.38
ALDH1A1 P00352 1/20 0.37
MEN1 O00255 1/20 0.37
ADRB2 P07550 1/20 0.37
KMT2A Q03164 1/20 0.37
DRD4 P21917 1/20 0.36
DRD5 P21918 1/20 0.36
DRD3 P35462 1/20 0.36
SIGMAR1 Q99720 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8939108 0.93 OPRM1 (0.40) MAOAMAOBHRH1CCR3OPRM1
SCHEMBL8937791 0.93 HRH1 (0.39) MAOAMAOBHRH1CCR3POLB
SCHEMBL8937591 0.91 SMN1; SMN2 (0.45) MAOAMAOBPOLBACHESIGMAR1
SCHEMBL8937636 0.91 MAOA (0.47) MAOAMAOBHRH1CCR3OPRM1
SCHEMBL8937740 0.90 OPRM1 (0.42) HRH1CCR3OPRM1KCNH2MEN1
SCHEMBL8939080 0.89 HRH1 (0.39) MAOAMAOBHRH1CCR3OPRM1
SCHEMBL8937576 0.87 OPRM1 (0.45) OPRM1BCHEACHEMEN1KMT2A
SCHEMBL8987720 0.86 BCHE (0.43) MAOAMAOBBCHEACHEALDH1A1
SCHEMBL8937316 0.86 DRD2 (0.40) MAOAMAOBHRH1CCR3KCNH2
SCHEMBL8937273 0.86 HRH1 (0.38) HRH1CCR3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2385047-B1 Piperidinyl-substituted isoquinolone derivatives SANOFI SA (FR) 2013-05-29 EP disclosed
US-8188117-B2 Piperidinyl-substituted isoquinolone derivatives SANOFI-AVENTIS (FR) 2012-05-29 US disclosed
US-8188117-B2 Piperidinyl-substituted isoquinolone derivatives SANOFI-AVENTIS (FR) 2012-05-29 US disclosed
EP-2385047-A1 Piperidinyl-substituted isoquinolone derivatives SANOFI (FR) 2011-11-09 EP disclosed
US-20090093518-A1 Piperidinyl-substituted isoquinolone derivatives SANOFI-AVENTIS (FR) 2009-04-09 US disclosed
US-20090093518-A1 Piperidinyl-substituted isoquinolone derivatives SANOFI-AVENTIS (FR) 2009-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090093518-A1 Piperidinyl-substituted isoquinolone derivatives MYLK2, MYLK, RHOT2 MAOA 2633/4885MAOB 2595/4885HRH1 2936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.